| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.02B | 48.98B | 45.01B | 41.64B | 35.27B | 28.31B |
| Gross Profit | 26.05B | 28.75B | 24.05B | 22.24B | 18.30B | 15.05B |
| EBITDA | 4.79B | 5.63B | 4.86B | 7.07B | 3.70B | 2.54B |
| Net Income | 2.62B | 2.10B | 2.94B | 3.95B | 1.93B | 1.24B |
Balance Sheet | ||||||
| Total Assets | 35.70B | 37.06B | 35.28B | 22.92B | 16.49B | 14.06B |
| Cash, Cash Equivalents and Short-Term Investments | 7.79B | 8.53B | 8.39B | 8.99B | 5.48B | 6.80B |
| Total Debt | 7.29B | 6.64B | 10.02B | 59.00M | 194.00M | 853.00M |
| Total Liabilities | 16.98B | 16.95B | 18.73B | 8.59B | 6.16B | 5.64B |
| Stockholders Equity | 17.38B | 18.64B | 16.54B | 14.33B | 10.33B | 8.41B |
Cash Flow | ||||||
| Free Cash Flow | 2.44B | 3.84B | -332.00M | 903.00M | -742.00M | 482.00M |
| Operating Cash Flow | 2.56B | 4.06B | 38.00M | 1.24B | 1.24B | 573.00M |
| Investing Cash Flow | 817.00M | 802.00M | -10.36B | 2.48B | -1.97B | -118.00M |
| Financing Cash Flow | -2.96B | -3.59B | 9.23B | -156.00M | -666.00M | -739.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥146.02B | 18.03 | ― | 5.00% | -1.45% | 1.16% | |
69 Neutral | ¥300.94B | 29.35 | 2.72% | 2.61% | 1.63% | 74.87% | |
69 Neutral | ¥83.24B | 20.79 | 7.23% | 3.53% | 6.10% | -9.89% | |
66 Neutral | ¥31.55B | 21.57 | ― | 1.81% | 3.27% | 13.82% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | ¥22.97B | 12.10 | ― | 0.91% | 7.04% | -34.37% |